Back to results
US 2026/0248763 A1Published application
Imine compounds as well as preparation method therefor and use thereof
AssigneeBio Genuine (Shanghai) Biotech Co., Ltd
InventorsPeng ZHANG, Kun LI, Wenwu YE, Xiaofeng CUI, Hejun LV
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to imine compounds as well as a preparation method therefor and the use thereof, in particular to compounds as shown in formula I. The compounds can be used for treating medical conditions such as premature delivery.
Claims28
A compound as shown in formula I:
- or an isotopic derivative thereof or a pharmaceutically acceptable salt of any of the foregoing;
- wherein X is N—OR1;
- R1 is hydrogen or C1-6 alkyl, and the C1-6 alkyl is optionally substituted with one or more R1a;
- each R1a is independently halogen, cyano, nitro, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, phenyl, 5- to 6-membered heteroaryl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl, halogenated C2-6 alkynyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, —OR5a, —SR5a, —N(R5a)(R5b), —C(O)R5a, —OC(O)R5a, —C(O)OR5a, —C(O)N(R5a)(R5b), —N(R5c)C(O)R5a, —N(R5c)C(O)N(R5a)(R5b), S(O)2R5a, —N(R5c)S(O)2R5a, —S(O)2N(R5a)(R5b), —Si(R5a)3, —Si(R5a)2(OR5b), —OSi(R5a)3, —Si(R5a)(OR5b)2, —OP(O)(OR5a)(OR5b), —P(O)(OR5a)(OR5b), —OP(O)(OR5a)(R5b), —P(O)(OR5a)(R5b), —OP(O)(R5a)(R5b) or —P(O)(R5a)(R5b);
- R3a is hydrogen, halogen, cyano, nitro, C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, phenyl, 5- to 6-membered heteroaryl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl, halogenated C2-6 alkynyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl or -L1-R3c;
- R3b is hydrogen, halogen, cyano, nitro, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl, halogenated C2-6 alkynyl, -L1-R3c, —C(O)OR3d, —C(O)N(R3d)(R3e), —S(O)2R3d, —S(O)2N(R3d)(R3e), —P(O)(OR3d)(OR3e), —P(O)(OR3d)(R3e), —P(O)(R3d)(R3e) C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl, and the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl optionally forms a fused ring with additional C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl;
- wherein the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl and 5- to 6-membered heteroaryl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl and halogenated C2-6 alkynyl;
- alternatively, R3a and R3b, together with the carbon atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl or 3- to 8-membered heterocycloalkenyl, and the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl and 3- to 8-membered heterocycloalkenyl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl and halogenated C2-6 alkynyl;
- each L1 is independently —[C(Ra)(Rb)]n—;
- wherein n is 1, 2 or 3;
- Ra and Rb are each independently hydrogen, C1-6 alkyl, C3-8 cycloalkyl or 3- to 8-membered heterocycloalkyl;
- alternatively, Ra and Rb, together with the carbon atom to which they are attached, form C3-8 cycloalkyl or 3- to 8-membered heterocycloalkyl;
- wherein the C1-6 alkyl, C3-8 cycloalkyl and 3- to 8-membered heterocycloalkyl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl and halogenated C2-6 alkynyl;
- each R3c is independently —OR7a, —SR7a, —N(R7a)(R7b), —C(O)R7a, —OC(O)R7a, —C(O)OR7a, —C(O)N(R7a)(R7b), —N(R7c)C(O)R7a, —N(R7c)C(O)N(R7a)(R7b), S(O)2R7a, —N(R7c)S(O)2R7a, —S(O)2N(R7a)(R7b), —Si(R7a)3, —Si(R7a)2(OR7b), —OSi(R7a)3, —Si(R7a)(OR7b)2, —OP(O)(OR7a)(OR7b), —P(O)(OR7a)(OR7b), —OP(O)(OR7a)(R7b), —P(O)(OR7a)(R7b), —OP(O)(R7a)(R7b) or —P(O)(R7a)(R7b);
- L2 is —[C(R10a)(R10b)]t—, wherein one C(R10a)(R10b) moiety is optionally replaced by —O— or —N(R10a)—;
- s is 1 and t is 1;
- alternatively, s is 2 and t is 1;
- alternatively, s is 1 and t is 2;
- R9a and R9b are each independently hydrogen, halogen, cyano, nitro, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl or halogenated C2-6 alkynyl;
- alternatively, R9a and R9b, together with the atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl or 3- to 8-membered heterocycloalkenyl;
- alternatively, R9a and R3a are joined to form —CH2— or —CH2CH2—;
- R10a and R10b are each independently hydrogen, halogen, cyano, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl or halogenated C2-6 alkynyl;
- alternatively, R10a and R10b, together with the carbon atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl or 3- to 8-membered heterocycloalkenyl;
- alternatively, R10a and R3a, together with the atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl or 3- to 8-membered heterocycloalkenyl;
- ring A is or
- wherein the * end is connected to the carbonyl group in formula I, and the # end is connected to ring B in formula I;
- each ---- bond is independently a single bond or a double bond;
- each A1 is independently CH, C(O), N, NH, O, S, N(R4a) or C(R4a);
- each A2 is independently CH, C(O), N, NH, O, S, N(R4b) or C(R4b) A3 is CH, C(O), N, N(R4c) or C(R4c);
- each A4 is independently CH, C(O), N, N(R4d) or C(R4d);
- A5 is CH, N, O, S, NH, C(R4d) or N(R4d);
- each A6 is independently C or N;
- each A7 is independently C or N;
- R4a, R4a, R4c and R4d are each independently halogen, cyano, nitro, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, phenyl, 5- to 6-membered heteroaryl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl, halogenated C2-6 alkynyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, —OR8a, —SR8a, —N(R8a)(R8b), —C(O)R8a, —OC(O)R8a, —C(O)OR8a, —C(O)N(R8a)(R8b), —N(R8c)C(O)R8a, —N(R8c)C(O)N(R8a)(R8b), —S(O)2R8a, —N(R8c)S(O)2R8a, —S(O)2N(R8a)(R8b), —Si(R8a)3, —Si(R8a)2(OR8b), —OSi(R8a)3, —Si(R8a)(0R8b)2, —OP(O)(OR8a)(OR8b), —P(O)(OR8a)(OR8b), —OP(O)(OR8a)(R8b), —P(O)(OR8a)(R8b), —OP(O)(R8a)(R8b) or —P(O)(R8a)(R8b);
- alternatively, R4a and R4b, together with the atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl;
- the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl and 5- to 6-membered heteroaryl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl and halogenated C2-6 alkynyl;
- in ring B, G1, G2 and G3 are each independently N or C(R2c);
- R2a, R2b and R2c are each independently hydrogen, halogen, cyano, nitro, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, phenyl, 5- to 6-membered heteroaryl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl, halogenated C2-6 alkynyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, —OR6, —SR6, —N(R6a)(R6b), —C(O)R6a, —OC(O)R6a, —C(O)OR6a, —C(O)N(R6a)(R6b), —N(R6c)C(O)R6a, —N(R6c)C(O)N(R6a)(R6b), —S(O)2R6a, —N(R6c)S(O)2R6a, —S(O)2N(R6a)(R6b), —Si(R6a)3, —Si(R6a)2(OR6b), —OSi(R6a)3, —Si(R6a)(OR6b)2, —OP(O)(OR6a)(OR6b), —P(O)(OR6a)(OR6b), —OP(O)(OR6a)(R6b), —P(O)(OR6a)(R6b), —OP(O)(R6a)(R6b) or —P(O)(R6a)(R6b);
- alternatively, R2b and R2a or R2c, together with the carbon atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl;
- the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl and 5- to 6-membered heteroaryl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl and halogenated C2-6 alkynyl;
- alternatively, R2a and R4b are joined to form —(CH2)p—, wherein p is 2, 3 or 4, and wherein one or two CH2 moieties are optionally replaced by —O— or —NH—;
- R3d, R3e, R5a, R5b, R6a, R6b, R7a, R7b, R5a and R5b are each independently hydrogen, C1-6 alkyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl, and the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl optionally forms a fused ring with additional C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl or 5- to 6-membered heteroaryl;
- wherein the C1-6 alkyl, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl and 5- to 6-membered heteroaryl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl, halogenated C2-6 alkynyl, C3-8 cycloalkenyl, 3- to 8-membered heterocycloalkenyl, phenyl and 5- to 6-membered heteroaryl;
- R5c, R6c, R7c and R8c are each independently hydrogen, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl or halogenated C2-6 alkynyl;
- in the aforementioned heterocycloalkyl, heterocycloalkenyl and heteroaryl, the number of heteroatoms is independently 1, 2, 3 or 4, and each heteroatom is independently N, O, S, Si, P and Se;
- provided that at least one of the following conditions (a), (b), (c), (d), and (e) is satisfied:
- condition (a):
- neither R2a nor R2b is hydrogen;
- moreover, when R2a is C1-6 alkyl, R3a is hydrogen and R3b is a group other than -L1-R3c, then R2b is not C1-6 alkyl;
- condition (b):
- R3a is C1-6 alkyl or -L1-R3c and R3b is -L-R3c;
- alternatively, R3a and R3b, together with the carbon atom to which they are attached, form C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl or 3- to 8-membered heterocycloalkenyl, and the C3-8 cycloalkyl, 3- to 8-membered heterocycloalkyl, C3-8 cycloalkenyl and 3- to 8-membered heterocycloalkenyl are optionally substituted with one or more substituents independently selected from halogen, hydroxyl, amino, cyano, oxo, C1-6 alkyl, C1-6 haloalkyl, C1-6 hydroxyalkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl, halogenated C2-6 alkenyl, C2-6 alkynyl and halogenated C2-6 alkynyl;
- condition (c):
- R3a is hydrogen, C1-6 alkyl or -L1-R3c;
- R3b is -L-R3c;
- ring A is
- wherein the * end is connected to the carbonyl group in formula I, and the # end is connected to ring B in formula I;
- moreover, R2a is not hydrogen;
- wherein each A1 is independently CH, N or C(R4a);
- each A2 is independently CH, N or C(R4b);
- each A3 is independently CH, N or C(R4c);
- each A4 is independently CH, N or C(R4d);
- A5 is O, S, NH or N(R4d);
- condition (d):
- R3b is —CH(C1-6 alkyl)-OH,
- —CH2NHC(O)CH2OH or —CH2OCH2CH2OH;
- condition (e):
- R9a and R3a are joined to form —CH2— or —CH2CH2—.
65 more elements
A compound, or an isotopic derivative thereof or a pharmaceutically acceptable salt of any of the foregoing, wherein the compound is any of the following compounds or a mixture of the compound and a stereoisomer thereof:
Dependencies are inferred from the claim text.